0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 21-40 of 194 Articles
Original Investigation | 
Kasia J. Lipska, MD, MHS; Joseph S. Ross, MD; Yun Wang, PhD; et al.
JAMA Intern Med. 2014;174(7):1116-1124. doi:10.1001/jamainternmed.2014.1824.
Includes: Supplemental Content

Perspective | 
Nicholas J. Rohrhoff, MD; Diana B. McNeill, MD; Joel C. Boggan, MD, MPH
JAMA Intern Med. 2014;174(7):1035-1036. doi:10.1001/jamainternmed.2014.1605.

Perspective | 
Carla Carnovale, PharmD; Mauro Venegoni, MD; Emilio Clementi, MD, PhD
JAMA Intern Med. 2014;174(7):1031-1032. doi:10.1001/jamainternmed.2014.1427.

Invited Commentary | 
Jeffrey Brent, MD, PhD
JAMA Intern Med. 2014;174(6):918-919. doi:10.1001/jamainternmed.2014.19.

Invited Commentary | 
June K. Robinson, MD
JAMA Intern Med. 2014;174(6):970-971. doi:10.1001/jamainternmed.2014.157.

Original Investigation | 
Wen-Qing Li, PhD; Abrar A. Qureshi, MD, MPH; Kathleen C. Robinson, PhD; et al.
JAMA Intern Med. 2014;174(6):964-970. doi:10.1001/jamainternmed.2014.594.
Includes: Supplemental Content

Case Report/Case Series | 
Emily Kern, MD; Lisa B. VanWagner, MD, MS; Guang-Yu Yang, MD, PhD; et al.
JAMA Intern Med. 2014;174(6):984-987. doi:10.1001/jamainternmed.2014.674.

Original Investigation | 
Bruce L. Davidson, MD, MPH; Sara Verheijen, BS; Anthonie W. A. Lensing, MD, PhD; et al.
JAMA Intern Med. 2014;174(6):947-953. doi:10.1001/jamainternmed.2014.946.

Original Investigation | 
Matthew Miller, MD, ScD; Sonja A. Swanson, ScM; Deborah Azrael, PhD; et al.
JAMA Intern Med. 2014;174(6):899-909. doi:10.1001/jamainternmed.2014.1053.
Includes: CME, Supplemental Content

Invited Commentary | 
Sei J. Lee, MD, MAS
JAMA Intern Med. 2014;174(5):686-688. doi:10.1001/jamainternmed.2013.13307.

Original Investigation | 
Andrew I. Geller, MD; Nadine Shehab, PharmD, MPH; Maribeth C. Lovegrove, MPH; et al.
JAMA Intern Med. 2014;174(5):678-686. doi:10.1001/jamainternmed.2014.136.
Includes: Supplemental Content

Viewpoint | 
Scott A. Flanders, MD; Sanjay Saint, MD, MPH
JAMA Intern Med. 2014;174(5):661-662. doi:10.1001/jamainternmed.2014.897.

Original Investigation | 
Jane A. Gwira Baumblatt, MD; Caleb Wiedeman, MPH; John R. Dunn, DVM, PhD; et al.
JAMA Intern Med. 2014;174(5):796-801. doi:10.1001/jamainternmed.2013.12711.

Special Communication | 
Steven Woloshin, MD, MS; Lisa M. Schwartz, MD, MS
JAMA Intern Med. 2014;174(4):615-619. doi:10.1001/jamainternmed.2013.14629.

Invited Commentary | 
Richard Kim, MD; Christopher H. Goss, MD, MS
JAMA Intern Med. 2014;174(4):574-576. doi:10.1001/jamainternmed.2013.13509.

Original Investigation | 
Robert MacLaren, PharmD, MPH; Paul M. Reynolds, PharmD; Richard R. Allen, PhD
JAMA Intern Med. 2014;174(4):564-574. doi:10.1001/jamainternmed.2013.14673.
Includes: Supplemental Content

Invited Commentary | 
Sarah D. Berry, MD, MPH; Douglas P. Kiel, MD, MPH
JAMA Intern Med. 2014;174(4):596-597. doi:10.1001/jamainternmed.2013.13746.

Original Investigation | 
Mary E. Tinetti, MD; Ling Han, MD, PhD; David S. H. Lee, PharmD, PhD; et al.
JAMA Intern Med. 2014;174(4):588-595. doi:10.1001/jamainternmed.2013.14764.

Invited Commentary | 
Seamus P. Whelton, MD, MPH; Sandeep Bansal, MD, MPH
JAMA Intern Med. 2014;174(3):345-346. doi:10.1001/jamainternmed.2013.11341.

Invited Commentary | 
Meyeon Park, MD, MAS; Chi-yuan Hsu, MD, MSc
JAMA Intern Med. 2014;174(3):355-356. doi:10.1001/jamainternmed.2013.12176.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Dermatology
Case Report/Case Series  | 
MEK Inhibitor–Induced Dusky Erythema:  Characteristic Drug Hypersensitivity Manifestation in 3 Patients
Urvi Patel, MD; Lynn Cornelius, MD; Milan J. Anadkat, MD
JAMA Dermatology
Original Investigation  | 
Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib
Rena C. Zuo, BA; Andrea B. Apolo, MD; John J. DiGiovanna, MD; et al.
JAMA Neurology
Editorial  | 
Fingolimod and Risk of Varicella-Zoster Virus Infection:  Back to the Future With an Old Infection and a New Drug
Kenneth L. Tyler, MD
JAMA Neurology
Original Investigation  | 
Varicella-Zoster Virus Infections in Patients Treated With Fingolimod:  Risk Assessment and Consensus Recommendations for Management
Ann M. Arvin, MD; Jerry S. Wolinsky, MD; Ludwig Kappos, MD, PhD; et al.